⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

DNLI News

Denali Therapeutics Inc. Common Stock

Denali Therapeutics Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome)